Genmab | Rentekostnader



Interest Expense On Debt Endring Dato
Agios Pharmaceuticals 3.01M 10.05M 2024-12
Amarin USD 0 8K 2024-06
Amgen USD 747M 29M 2024-12
argenx SE 704K 28K 2024-12
AstraZeneca 429M 28M 2024-12
Bayer 703M 61M 2024-12
BioMarin Pharmaceutical USD 2.58M 391K 2024-12
Demant 462M 438.85M 2024-12
Exelixis 23.4M 3.9M 2023-09
Fresenius Medical Care EUR 101M 2M 2024-12
Galapagos EUR 50.12M 49.87M 2024-09
Genmab DKK 2.68B 1.98B 2024-12
GlaxoSmithKline 173M 17M 2024-12
GN Store Nord 295M 280.5M 2024-12
GRIFOLS EUR 202.71M 94.07M 2024-06
Hikma Pharmaceutical 22M 9M 2024-06
Insmed USD 19.8M 532K 2024-12
Lonza CHF 59M 6M 2024-06
Merck 76M 13M 2024-12
Novartis USD 275M 11M 2024-12
Regeneron Pharmaceuticals USD 10.5M 3.3M 2024-12
Roche Holding CHF 311.5M 1000K 2024-12
Sanofi 62M 17M 2024-12



Genmab Rentekostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.